Found: 31
Select item for more details and to access through your institution.
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 12, p. 1205, doi. 10.3390/pharmaceutics12121205
- By:
- Publication type:
- Article
Brain barriers virtual: an interim solution or future opportunity?
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00314-2
- By:
- Publication type:
- Article
How Much is Enough? Impact of Efflux Transporters on Drug delivery Leading to Efficacy in the Treatment of Brain Tumors.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2731, doi. 10.1007/s11095-023-03574-1
- By:
- Publication type:
- Article
To Measure is to Know: A Perspective on the Work of Dr. Margareta Hammarlund-Udenaes.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 7, p. 1297, doi. 10.1007/s11095-022-03225-x
- By:
- Publication type:
- Article
Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 9, p. 1, doi. 10.1007/s11095-018-2455-9
- By:
- Publication type:
- Article
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
- By:
- Publication type:
- Article
Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0141506
- By:
- Publication type:
- Article
Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2007, v. 27, n. 5, p. 1033, doi. 10.1038/sj.jcbfm.9600414
- By:
- Publication type:
- Article
Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 96, n. 3, p. 217, doi. 10.1007/s10549-005-9004-z
- By:
- Publication type:
- Article
Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63494-7
- By:
- Publication type:
- Article
Changes in the vasculature of human brain tumors: Implications for treatment.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 1995, doi. 10.1093/neuonc/noab220
- By:
- Publication type:
- Article
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1422, doi. 10.1093/neuonc/noaa142
- By:
- Publication type:
- Article
Comments on: "Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1404, doi. 10.1093/neuonc/noaa112
- By:
- Publication type:
- Article
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 184, doi. 10.1093/neuonc/nox175
- By:
- Publication type:
- Article
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 1, p. 128, doi. 10.1093/neuonc/now135
- By:
- Publication type:
- Article
Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 1, p. 27, doi. 10.1093/neuonc/nov164
- By:
- Publication type:
- Article
CNS Anticancer Drug Discovery and Development Conference White Paper.
- Published in:
- Neuro-Oncology, 2015, v. 17, p. vi1, doi. 10.1093/neuonc/nov169
- By:
- Publication type:
- Article
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 9, p. 1210, doi. 10.1093/neuonc/nov081
- By:
- Publication type:
- Article
Unsanctifying the sanctuary: challenges and opportunities with brain metastases.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 5, p. 639, doi. 10.1093/neuonc/nov023
- By:
- Publication type:
- Article
INFLUENCE OF DRUG DELIVERY ON THERAPEUTIC BENEFIT IN GBM–CDK4 AND MDM2 INHIBITOR COMPARISON IN FLANK VERSUS ORTHOTOPIC MODELS AND COMPARISON OF BRAIN PENETRANT VERSUS IMPENETRANT PI3K/MTOR INHIBITORS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii33, doi. 10.1093/neuonc/nou208.40
- By:
- Publication type:
- Article
Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 65, doi. 10.1215/S1152851703000103
- By:
- Publication type:
- Article
The influence of the blood–brain barrier in the treatment of brain tumours.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 1, p. 3, doi. 10.1111/joim.13440
- By:
- Publication type:
- Article
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad066
- By:
- Publication type:
- Article
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad033
- By:
- Publication type:
- Article
Methodological and analytical considerations for intra-operative microdialysis.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00497-2
- By:
- Publication type:
- Article
Methodological and analytical considerations for intra-operative microdialysis.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00497-2
- By:
- Publication type:
- Article
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05035-2
- By:
- Publication type:
- Article
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 734, p. 1, doi. 10.1126/scitranslmed.adj5962
- By:
- Publication type:
- Article
Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls.
- Published in:
- Obesity Surgery, 2021, v. 31, n. 10, p. 4289, doi. 10.1007/s11695-020-04969-4
- By:
- Publication type:
- Article
Bayesian Approach to Estimate AUC, Partition Coefficient and Drug Targeting Index for Studies with Serial Sacrifice Design.
- Published in:
- Pharmaceutical Research, 2014, v. 31, n. 3, p. 649, doi. 10.1007/s11095-013-1187-0
- By:
- Publication type:
- Article
AAPS-FDA Workshop White Paper: Microdialysis Principles, Application and Regulatory Perspectives.
- Published in:
- Pharmaceutical Research, 2007, v. 24, n. 5, p. 1014, doi. 10.1007/s11095-006-9206-z
- By:
- Publication type:
- Article